Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR): a National Multi-center, Retrospective-prospective, Cohort Study Initiated by the Investigators
First Affiliated Hospital Xi'an Jiaotong University
2,000 participants
May 9, 2024
OBSERVATIONAL
Conditions
Summary
In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.
Eligibility
Inclusion Criteria1
- Patients with clinically confirmed infective endocarditis
Exclusion Criteria2
- Patients refuse to sign informed consent form
- Patients who combined with serious systemic diseases, cannot tolerate the acquisition of biological samples
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Observational; No Interventions were given.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05965362